Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06168994
PHASE4
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of atrial fibrillation in patient with structural heart disease
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-02-01
Completion Date
2027-05-20
Last Updated
2023-12-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Eplerenone
Amiodarone vs eplerenone in AF